With so much focus on the Delta variant and breakthrough COVID, there is an escalating public health threat that requires our attention and action: Long COVID. It is on track to long outlast the pandemic, and its enduring impact on public health in America could be more profoundly devastating than we can currently predict. Formally […]

What if a smartphone could detect your patients’ risk of developing a chronic condition such as type 2 diabetes, heart disease or stroke? What if patients could use a smartphone app to initiate a scan that provided direct feedback on a suspicious lesion on their skin? Through an easy-to-use app, suppose your patients could measure […]

Big developers tend to dominate the vast oncology meetings and this year’s Esmo was no exception. Astrazeneca, with a plenary spot for Enhertu and several well-received presentations on other projects, was the dominant big pharma name. Among the smaller biotechs a couple of winners stand out, according to Evaluate Vantage’s analysis of share price moves over the […]